Rodríguez-Guzmán R, Céspedes MEM, Suárez CN, Guzmán-Díaz P

Language: Spanish
References: 15
Page: 1-5
PDF size: 226.73 Kb.

Text Extraction

No abstract.

REFERENCES

1. González Rey T, Savon Martin LM, Travieso Pérez SM, Maurisset Cintero Y. Disfunción endotelial en una etapa precoz del diagnóstico de hipertensión arterial. Rev Cubana Med. 2020[acceso: 22/09/2020];59(2). Disponible en: Disponible en: http://revmedicina.sld.cu/index.php/med/article/view/1363

2. Céspedes Miranda EM, Rodríguez Guzmán R, Suárez Castillo N. Ácido úrico y estrés oxidativo contribuyen a la enfermedad cardiovascular a través de la disfunción endotelial y la insulinorresistencia. Rev. Cubana Invest. Bioméd. 2019[acceso: 24/12/2019];38(4). Disponible en: Disponible en: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/241

3. Gao L, Thakur A, Siu PM, Lai CWK. Role of free fatty acids in endothelial dysfunction. J Biomed Sci. 2017;24(1):50. Disponible en: https://doi.org//10.1186/s12929-017-0357-5

4. Tesauro M, Mauriello A, Rovella V, Annicchiarico‐Petruzzelli M, Cardillo C. Arterial ageing: from endothelial dysfunction to vascular calcification. Journal of Internal Medicine, 2017;281:471-82. Disponible en: https:// doi.org//10.1111/joim.12605

5. Zhu W, Yuan Y, Liao G. Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy. Cell Death Dis. 2018[acceso: 24/12/2019];837:9. Disponible en: Disponible en: https://www.nature.com/articles/s41419-018-0861-x

6. Dharmashankar K, Widlansky ME. Vascular Endothelial functions and Hypertension: Insights and Directions. Curr Hypertens Rep. 2010;12(6):448-55. Disponible en: https://doi.org//10.1007/511906-010-0150-2

7. Hadi ARH, Carr CS, Swaidi JA. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vascular health and Risk Management. 2005;1(3):183-198.

8. Muñoz-Durango N, Fuentes CA, Castillo AE, Gónzalez- Gómez LM, Vecchiola A, Fardella CE. Role of the Renin- Angiotensin-Aldosterone System Beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension. Int. J. Mol. Sci. 2015;17:797. Disponible en: https://doi.org/10.3390/ijms17070797

9. Schiffrin EL, Park JB, Intengan HD, Touzy M. Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by Angiotensin Receptor Antagonist Losartan. Circulation. 2000:1653-56. Disponible en: https://doi.org/10.1161/01cr.101.14.1653

10. Soto A, Cvetkovic Vega A. Estudios de casos y controles. Rev. Fac. Med. Hum. 2020[acceso: 24/12/2019];20(1):138-43.

11. Chong Chen, Damir B. Khismatullin Oxidized Low-Density Lipoprotein Contributes to Atherogenesis via Co-activation of Macrophages and Mast Cells. PLoS One. 2015;10(3):e0123088. Disponible en: https://doi.org//10.1371/journal.pone.0123088

12. Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascul Pharmacol. 2016 Sep;84:1-7. Disponibles en: https://doi.org//10.1016/j.vph.2016.05.013

13. Molavi F, Namazi N, Asadi M, Sanjari M, Motlag ME, Shafii G, et al. Comparison common equations for LDL-C calculation with direct assay and developing a novel formula in Iranian children and adolescents: the CASPIAN study. Lipids Health Disease. 2020;19(129).

14. Scioli MG, D'Amico F, Rodríguez R, Céspedes EM, Orlandi A. Oxidative Stress-Induced Endothelial Dysfunction Contributes To Cardiovascular Disease. Rev Cubana Inv Bioméd. 2019[acceso: 22/09/2020];38(1). Disponible en: Disponible en: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/168

15. Scioli MG, Storti G, D’Amico F, Rodríguez R, Centofanti F, Doldo E, et al. Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets. J Clin Med. 2020;9(6):1995. PMCID: PMC7355625 PMID: 32630452. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355625/